Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers | Zendy

Tommaso Giani | Zendy; Fabio Arena | Zendy; Simona Pollini | Zendy; Vincenzo Di Pilato | Zendy; Marco Maria D’Andrea | Zendy; Lucia Henrici De Angelis | Zendy; Matteo Bassetti | Zendy; Gian María Rossolini | Zendy; Chiara Vismara | Zendy; Francesco Luzzaro | Zendy; Rossana Cavallo | Zendy; Pier Andrea Dusi | Zendy; Elisabetta Pagani | Zendy; Mario Sarti | Zendy; Claudio Farina | Zendy; R. Rigoli | Zendy; Claudio Scarparo | Zendy; Patrizia Pecile | Zendy; Maria Grazia Cusi | Zendy; Antonella Mencacci | Zendy; Esther Manso | Zendy; Teresa Spanu | Zendy; Maria Labonia | Zendy; V Tassi | Zendy; Gerardino Amato | Zendy; Stefania Stefani | Zendy; Cristina Giraldi | Zendy; Mario Rassu | Zendy

Open Access

Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers

Author(s) -

Tommaso Giani,

Fabio Arena,

Simona Pollini,

Vincenzo Di Pilato,

Marco Maria D’Andrea,

Lucia Henrici De Angelis,

Matteo Bassetti,

Gian María Rossolini,

Chiara Vismara,

Francesco Luzzaro,

Rossana Cavallo,

Pier Andrea Dusi,

Elisabetta Pagani,

Mario Sarti,

Claudio Farina,

R. Rigoli,

Claudio Scarparo,

Patrizia Pecile,

Maria Grazia Cusi,

Antonella Mencacci,

Esther Manso,

Teresa Spanu,

Maria Labonia,

V Tassi,

Gerardino Amato,

Stefania Stefani,

Cristina Giraldi,

Mario Rassu

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx453

Subject(s) - colistin , broth microdilution , pseudomonas aeruginosa , tazobactam , microbiology and biotechnology , biology , cephalosporin , antimicrobial , amikacin , antibiotics , minimum inhibitory concentration , antibiotic resistance , bacteria , imipenem , genetics

Pseudomonas aeruginosa is a major cause of severe healthcare-associated infections and often shows MDR phenotypes. Ceftolozane/tazobactam is a new cephalosporin/β-lactamase inhibitor combination with potent activity against P. aeruginosa. This survey was carried out to evaluate the susceptibility of P. aeruginosa, circulating in Italy, to ceftolozane/tazobactam and comparators and to investigate the molecular epidemiology of carbapenemase-producing strains.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research